A Prospective Study to Determine the Effectiveness of Reaming in Reducing Fat Emboli to the Lungs
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of the study is to see if there is a difference in the amount of fat droplets reaching the heart during surgery between the standard reamer currently used and a new reamer system which is expected to reduce the fat going into the blood, via an intraoperative echocardiography done through the food pipe.
| Condition | Intervention |
|---|---|
|
Diaphyseal Femur Fracture |
Procedure: Transesophageal transducer Procedure: echocardiography |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Using Transesophageal Echocardiography To Assess Fat Emboli As A Result Of Reaming In A Prospective Randomized Control Trial To Determine The Effectiveness Of Reaming In Diminishing Fat Emboli To The Lungs |
- Presence of Emboli [ Time Frame: Immediately following surgery ] [ Designated as safety issue: Yes ]
| Estimated Enrollment: | 24 |
| Study Start Date: | May 2006 |
| Study Completion Date: | January 2010 |
| Primary Completion Date: | December 2009 (Final data collection date for primary outcome measure) |
-
Procedure: Transesophageal transducer
Reamed intramedullary nailing of diaphyseal femur fractures remains the standard of care for treatment of these fractures. Pressurization of the femoral canal during reaming leads to extra vasations of fat emboli into the systemic circulation, resulting in deposition of fat droplets in the pulmonary vasculature. This phenomenon has been well documented by use of Transesophageal Echocardiography. A novel reaming system has recently become available that may limit this phenomenon. The new reamer system incorporates irrigation and aspiration during reaming, theoretically minimizing pressurization and fat emboli. Additionally, this reamer system allows for one pass reaming as compared to the current system which requires multiple reaming passes.
The objective of this study is to determine effectiveness of reaming in diminishing fat emboli to the lungs as evidenced by decreased numbers of large fat droplets entering the right heart as measured by transesophageal echocardiography during the reaming process. This will determine if there is a benefit to aspiration during reaming as would be expected.
During the reaming process a transesophageal echo cardiogram will be performed to analyze the presence or absence of emboli and the mean regarding the total time that each of the embolic grades is present during each of the intervals across the patient groups
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- diaphyseal femur fractures undergoing reamed intramedullary nailing
- male or female
- 18 years of age or older
Exclusion Criteria:
- None
Contacts and Locations| United States, Kentucky | |
| University of Kentucky Chandler Medical Center | |
| Lexington, Kentucky, United States, 40536 | |
| Principal Investigator: | William Rosenblum, MD | University of Kentucky, Department of Orthopaedic Surgery |
| Principal Investigator: | Jeffrey Selby, MD | University of Kentucky Department of Orthopaedic Surgery |
More Information
No publications provided
| Responsible Party: | Jeffrey Selby, UK Orthopaedics |
| ClinicalTrials.gov Identifier: | NCT00327158 History of Changes |
| Other Study ID Numbers: | 06-0296-F1V |
| Study First Received: | May 16, 2006 |
| Last Updated: | January 27, 2010 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by University of Kentucky:
|
Reaming fracture emboli |
Additional relevant MeSH terms:
|
Embolism, Fat Femoral Fractures Fractures, Bone Embolism Embolism and Thrombosis |
Vascular Diseases Cardiovascular Diseases Wounds and Injuries Leg Injuries |
ClinicalTrials.gov processed this record on June 17, 2013